Joby Aviation, Inc. (JOBY)

Key Updates

Joby Aviation shares fell a further 4.32% since the September 1, 2026 report, closing at $6.42 and marking a fifth consecutive reporting period of losses. The decline includes a sharp 6.14% single-day drop coinciding with a September 9 Form 8-K disclosing an unspecified departure/election of directors or officers. While the filing itself is characterized as non-material governance disclosure, the timing amid an already fragile technical setup appears to have weighed on sentiment. No new operational or financial catalysts were disclosed beyond the previously reported Resonant Sciences defense acquisition.

Current Trend

JOBY remains in a well-established downtrend, now down 51.36% YTD and 36.06% over six months. The stock has broken below all prior support levels referenced in previous reports ($8.71 in early August, $7.50 on August 19, $6.71 on September 1), each of which has sequentially become resistance. The 1-month decline of 27.13% indicates the downtrend is accelerating rather than stabilizing. There is no evidence in the price data of a base or reversal pattern; the trend structure remains one of lower highs and lower lows with no confirmed support level identified below the current $6.42 price.

Investment Thesis

The core thesis for Joby rests on successful commercialization of its eVTOL air taxi platform, progress toward FAA certification, and an emerging diversification into the defense sector via the pending Resonant Sciences acquisition, intended to establish "Joby Defense" as a new revenue stream. Industry-wide consolidation — exemplified by Archer Aviation's acquisition of Wisk Aero, SkyGrid, and Insitu from Boeing — signals a maturing competitive landscape where scale and diversified capabilities may determine long-term survivors. However, Joby remains a pre-revenue, cash-consuming business, and the August 11 unregistered equity sale disclosed in the 8-K raises dilution concerns that must be weighed against the company's expanding strategic footprint.

Thesis Status

The thesis is increasingly strained. The persistent five-report losing streak, cumulative YTD loss exceeding 51%, and now a leadership/governance disclosure introduce incremental uncertainty at a time when the stock is already technically impaired. The defense diversification via Resonant Sciences remains a legitimate medium-term positive, but its financial terms ($500 million, per TechCrunch) and financing structure (partly via unregistered equity issuance) suggest near-term dilution risk that the market appears to be pricing in aggressively. Until the company demonstrates stabilization in price action or provides clarity on the September 9 leadership change, the thesis should be considered under pressure rather than validated.

Key Drivers

The dominant driver since the last report is the September 9 Form 8-K disclosing a director/officer departure or election, which preceded the sharpest single-day decline in the recent series. This follows the August 11 8-K disclosing a material agreement and unregistered equity sale, tied to the Cerberus-to-Joby sale of Resonant Sciences, expected to close in H1 2027. Broader sector context is provided by the TechCrunch Mobility report, which frames the $500 million Resonant deal alongside Archer Aviation's acquisition of Wisk Aero from Boeing as evidence of accelerating eVTOL industry consolidation.

Technical Analysis

JOBY trades at $6.42, having broken decisively below the $6.71 level that served as the prior report's closing reference and near-term support. The stock's 1-day (-6.14%), 5-day (-4.04%), and 1-month (-27.13%) figures collectively indicate accelerating downside momentum rather than consolidation. With no historical support level intact within the provided data below current levels, the stock is in price-discovery mode to the downside. Resistance is now expected in the $6.71–$7.50 zone, representing the last two broken support levels. The magnitude and consistency of the multi-week decline suggest the stock remains technically oversold, but no reversal signal is evident in the data provided.

Bull Case

• Defense sector diversification: The pending $500 million acquisition of Resonant Sciences establishes "Joby Defense," adding a new revenue stream in radar, navigation, and RF mission systems (PR Newswire, TechCrunch)
• Industry consolidation validates sector viability: Archer Aviation's acquisition of Wisk Aero, SkyGrid, and Insitu from Boeing signals maturing competitive dynamics that could benefit well-capitalized survivors like Joby (TechCrunch)
• Additional capital access: The August 11 8-K confirms the company secured a material agreement and completed an equity sale, providing incremental liquidity to fund operations and the Resonant acquisition (SEC EDGAR)
• Continued certification pursuit: Joby continues to pursue air taxi certification alongside its new defense business line, maintaining its core commercialization pathway (TechCrunch)
• Technically oversold conditions: A 51.36% YTD decline and 27.13% one-month drop raise the statistical probability of a near-term technical bounce, though no reversal signal is yet confirmed

Bear Case

• Uninterrupted downtrend: Shares have declined in five consecutive reporting periods, down 51.36% YTD, 36.06% over six months, and 27.13% over the past month, with no signs of stabilization
• Equity dilution risk: The August 11 8-K discloses an unregistered sale of equity securities, raising concerns about shareholder dilution to fund operations and the Resonant acquisition (SEC EDGAR)
• Leadership uncertainty: The September 9 8-K disclosing a director/officer departure introduces governance uncertainty during an already fragile period, coinciding with the sharpest single-day price decline in the recent series (SEC EDGAR)
• Capital intensity of new acquisition: The $500 million Resonant Sciences deal, expected to close in H1 2027, adds integration and financing burden to a company still pre-revenue on its core air taxi business (TechCrunch)
• Broken technical support: The stock has breached all prior support levels referenced in earlier reports ($8.71, $7.50, $6.71), with accelerating downside momentum and no new support level established